Anixa Biosciences, Inc. (ANIX)
NASDAQ·Healthcare·Biotechnology
$3.16
+4.15%
Mkt Cap $99.47M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+90.1%
Consensus $6.00 vs current $3.16
NASDAQ·Healthcare·Biotechnology
$3.16
+4.15%
Mkt Cap $99.47M
No recent rating data.
Price Target (4 analysts)
$6.00
Range $6.00 – $6.00
+90.1%
Consensus $6.00 vs current $3.16